| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-11 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-11 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |